GALAXY FOODS CO
PRES14A, 1999-01-05
DAIRY PRODUCTS
Previous: COVA SERIES TRUST, 497, 1999-01-05
Next: VARIABLE ACCOUNT I OF AIG LIFE INS CO, 497, 1999-01-05




<PAGE> 1

	SCHEDULE 14A INFORMATION


	Proxy Statement Pursuant to Section 14(a) of the Securities 
Exchange Act of 1934

	(Amendment No. _______)


   	X    		Filed by the Registrant

   	___	  	Filed by a Party other than the Registrant

Check the appropriate box:

	X    		Preliminary Proxy Statement

	_____		Confidential, for Use of the Commission Only (as permitted by	
        Rule 14a-6(e)(2))

	_____		Definitive Proxy Statement

	_____		Definitive Additional Materials

	_____		Soliciting Material Pursuant to Section 240.14a-11(c) or 
        Section 240.14a-12


GALAXY FOODS COMPANY, a Delaware corporation
(Name of Registrant as Specified In Its Charter)


(Name of Person(s) Filing Proxy Statement if other than the 
Registrant)

		Payment of Filing Fee (Check the approximate box)

    X    		No fee required.

   ___   		Fee computed on table below per Exchange Act Rules 
14a-6(i)(4) and O-11.

				1.	Title of each class of securities to which transaction applies:
					
				2.	Aggregate number of securities to which transaction applies:
					
				3.	Per unit price or other underlying value of transaction computed 
       pursuant to Exchange Act Rule O-11 (set forth the 
       amount on which the filing fee is calculated and state how it was 
       determined):
				
				4.	Proposed maximum aggregate value of transaction:

<PAGE> 2
					
				5.	Total fee paid:

_____		Fee paid previously with preliminary materials.

_____		Check box if any part of the fee is offset as 
provided by Exchange Act Rule O-11(a)(2) and identify the filing 
for which the offsetting fee was paid previously.  Identify the 
previous filing by registration statement number, or the Form or 
Schedule and the date of its filing.

				1.	Amount Previously Paid:
	
				2.	Form, Schedule or Registration Statement No.:
	
				3.	Filing Party:

				4.	Date Filed:



<PAGE> 3

GALAXY FOODS COMPANY

2441 Viscount Row

Orlando, Florida 32809



NOTICE OF SPECIAL MEETING OF SHAREHOLDERS

TO BE HELD THURSDAY, FEBRUARY 11, 1999 


To the Shareholders:

The Special Meeting of Shareholders of Galaxy Foods Company (the 
"Company") will be held Thursday, February 11, 1999 at 10:00 a.m. 
at the offices of the Company in Orlando, Florida for the 
following purposes:

1. 	To consider and vote upon a proposal by the Board of 
Directors to effect a one-for-seven reverse stock split of the 
Company's common stock, par value $0.01 per share. 

2. 	To transact such other business as may properly come before 
the meeting and any adjournment thereof.

Shareholders of record at the close of business on January 7, 
1999 will be entitled to vote at the meeting or any adjournment 
thereof.

By Order of the Board of Directors


/s/Cynthia L. Hunter
Cynthia L. Hunter

Corporate Secretary





Orlando, Florida
January 5, 1999


SHAREHOLDERS ARE REQUESTED TO SIGN THE ENCLOSED PROXY AND RETURN 
IT IN THE ENCLOSED STAMPED ENVELOPE BY RETURN MAIL.  IF YOU 
ATTEND THE MEETING, YOU MAY REVOKE YOUR PROXY AND VOTE IN PERSON.




<PAGE>4

GALAXY FOODS COMPANY	
2441 Viscount Row
Orlando, Florida 32809

January 5, 1999

PROXY STATEMENT FOR THE SPECIAL MEETING OF SHAREHOLDERS to be 
held Thursday, February 11, 1999

Proxies in the form enclosed with this proxy statement are 
solicited by the Board of Directors of Galaxy Foods Company (the 
"Company"), a Delaware corporation, for the use at the Special 
Meeting of Shareholders to be held Thursday, February 11, 1999 at 
10:00 a.m. at the offices of the Company in 
Orlando, Florida.

Only shareholders of record as of January 7, 1999 will be 
entitled to vote at the meeting and any adjournment thereof.  As 
of January 5, 1999, 64,217,051 shares of Common Stock, par value 
$.01 per share, of the Company were issued 
and outstanding.  Each share of Common Stock outstanding as of 
the record date will be entitled to one vote, and shareholders 
may vote in person or by proxy. Execution of a proxy will not, in 
any way, affect a shareholders' right to 
revoke it by written notice to the Secretary of the Company at 
any time before it is exercised or by delivering a later executed 
proxy to the Secretary of the Company at any time before the 
original proxy is exercised.

Where a choice has been specified on the proxy with respect to 
the matters to be voted thereunder, the shares represented by the 
proxy will be voted in accordance with the specification, and 
will be voted FOR if no specification is 
indicated.

The Board of Directors knows of no other matter to be presented 
at the meeting. If any other matter should be presented at the 
meeting upon which a vote might be taken, shares represented by 
all proxies received by the Board of Directors will be voted with 
respect thereto in accordance with the judgment of the persons 
named as attorneys in the proxies. This proxy statement and the 
form of proxy were first mailed to shareholders on or about 
____________, 1999.





SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS

The following table sets forth, to the knowledge of Management, 
each person of entry who is the beneficial owner of more than 5% 
of the 64,217,051 shares of the Company's Common Stock, $.01 par 
value ("Common Stock"), outstanding as of January 5, 1999, the 
number of shares owned by each such person and the percentage of 
the outstanding shares represented thereby.


<PAGE> 5

                            					 	Amount and	
Name and Address	                  Nature of			           	Percent 
of Beneficial Owner	            Beneficial Ownership(1)  	of Class(2)	

Angelo S. Morini 
2441 Viscount Row
Orlando, Florida 32809              25,120,199 (3)         38.1%

Cede & Co.
Box #20
Bowling Green Station
New York, New York                  35,525,107 (4)        	53.8%

(1)  The inclusion herein of any shares deemed beneficially owned 
does not constitute an admission of beneficial ownership of these 
shares.  

(2)  The total number of shares outstanding assuming the exercise 
of all currently exercisable and vested options and warrants held 
by all executive officers, current directors, and holders of 5% 
or more of the Company's issued and outstanding Common Stock is 
68,525,940 shares.  Does not assume the exercise of any other 
options or warrants.

(3)  Includes options to acquire 1,091,500 shares of the 
Company's Common Stock.  These options include an option issued 
on October 1, 1991 to acquire 91,500 shares of the Company's 
stock at $3.575 per share.  The original exercise 
price of this option was reduced by the Board of Directors to 
$.50 per share on August 31, 1993.  On October 1, 1996, the term 
to exercise this option was extended to October 1, 2001.  On July 
1, 1997, Mr. Morini was granted an option to acquire 1,000,000 
shares of the Company's Common Stock at an exercise price of 
$0.75 per share under the terms of his employment agreement, 
which option expires on July 1, 2002.  The closing bid price of 
the Company's stock on the inter-dealer quotation system operated 
by Nasdaq, Inc. (the "NASDAQ System") on June 30, 1997 was $0.75.  
Also includes 5,000 shares owned by Mr. Morini that are held in a 
nominee name and 2,000 shares held in joint tenancy.  The 
remaining 24,021,699 shares beneficially owned by Mr. Morini are 
owned of record by Morini Investments Limited Partnership, a 
Delaware limited partnership, of which Mr. Morini is the sole 
limited partner holding a 99% ownership interest in such 
partnership.  The general partner of Morini Investments Limited 
Partnership is Morini Investments, LLC, a Delaware limited 
liability company, of which Mr. Morini is the sole member.  
Morini Investments, LLC holds a 1% ownership interest in Morini 
Investments Limited Partnership.  

(4)  Cede & Co. is a share depository used by shareholders to 
hold stock in street name.  Does not include 5,000 shares 
beneficially owned by Angelo S. Morini and held by Cede & Co. in 
street name.

<PAGE> 6
SECURITY OWNERSHIP OF MANAGEMENT
 
The following table sets forth, as of January 5, 1999, the number 
of shares owned directly, indirectly and beneficially by each 
executive officer and each director and director-nominee of the 
Company, and by all executive officers and directors as a group:
 
	                       					Amount and
Name and Address	            Nature of			      	    Percent of
of Beneficial Owner	      Beneficial Ownership(1)     Class(2)

Angelo S. Morini
Galaxy Foods Company
2441 Viscount Row
Orlando, Florida  32809	  		 25,120,199 (3)			          38.1%

Earl G. Tyree
240 North Line Drive
Apopka, Florida  32703		    	    22,000 (4)		             	*

Douglas A. Walsh
607 Tamiami Trail
Ruskin, Florida  33570		         22,667 (5)			            	*

Marshall K. Luther
Galaxy Foods Company
2441 Viscount Row
Orlando, Florida  32809		     	 127,333 (6)	             		*	
		
Cynthia L. Hunter
Galaxy Foods Company
2441 Viscount Row
Orlando, Florida  32809		        32,000 (7)	              	*	

All executive officers and
directors as a group			      25,374,199		             		38.4%
				
*  Less than 1%


(1)  The inclusion herein of any shares deemed beneficially owned 
does not constitute an admission of beneficial ownership of these 
shares.

(2)  The total number of shares outstanding assuming the exercise 
of all currently exercisable and vested options and warrants held 
by all executive officers, directors, and holders of 5% or more 
of the Company's issued and outstanding Common Stock is 68,525,940 shares.  
Does not assume the exercise of any other options or warrants.

(3) Includes options to acquire 1,091,500 shares of the Company's 
Common Stock.  These options include an option issued on October 
1, 1991 to acquire 91,500 shares of the Company's stock at $3.575 
per share.  The original exercise 
price of this option was reduced by the Board of Directors to 
$.50 per share on August 31, 1993.  On October 1, 1996, the term 
to exercise this option was extended to October 1, 2001 on 
October 1, 1996.  On July 1, 1997, Mr. Morini was granted an 
option to acquire 1,000,000 shares of the Company's Common Stock 
at an exercise price of $0.75 per share under the terms of his 
employment agreement, which option expires on July 1, 2002.  The 
closing bid price of the Company's stock as quoted on the NASDAQ 
System on June 30, 1997 was $0.75.  Also includes 5,000 shares 
owned by Mr. Morini that are held in a nominee name and 2,000 
shares held in joint tenancy.  The remaining 24,021,699 shares 
beneficially owned by Mr. Morini are owned of record by Morini 
Investments Limited Partnership, a Delaware limited partnership, 
of which Mr. Morini is the sole limited partner holding a 99% 
ownership interest in such partnership.  The general partner of 
Morini Investments Limited Partnership is Morini Investments, 
LLC, a Delaware limited liability company, of which Mr. Morini is 
the sole member.  Morini Investments, LLC holds a 1% ownership 
interest in Morini Investments Limited Partnership.  

<PAGE> 7
4)  Mr. Tyree, a current member of the Board of Directors, was 
granted an option to acquire 15,000 shares of Common Stock on 
September 11, 1992 for an exercise price of $2.88 per share.  
This option expires on September 11, 2002.  The 
closing bid price of the Company's Common Stock as reported on 
the  NASDAQ System on September 10, 1992 was $2.875 per share.  
Mr. Tyree was granted an additional option on October 1, 1993 to 
acquire 1,000 shares of Common Stock at 
an exercise price of $2.125 per share.  This option expires on 
October 1, 2003.  The closing bid price of the Company's Common 
Stock as quoted on the NASDAQ System on September 30, 1993 was 
$2.00 per share.  The exercise price of all of Mr. Tyree's then 
existing options was reduced to $2.00 per share on January 31, 
1994.  The closing bid price of the Company's Common Stock as 
quoted on the NASDAQ System on January 28, 1994 was $4.625 per 
share.  On October 1, 1994, Mr. Tyree was granted an option to 
acquire 1,000 shares at an exercise price of $2.75 per share.  
The closing bid price of the Company's Common Stock as quoted on 
the NASDAQ System on September 30, 1994, was $2.875 per share.  
This option expires on October 1, 2004.  On October 1, 1995, Mr. Tyree was 
granted an option to acquire 1,000 shares at an exercise price of 
$0.59 per share.  The closing bid price of the Company's Common 
Stock as quoted on the NASDAQ System on 
September 29, 1995, was $0.59375 per share.  This option expires 
on October 1, 2005.  On October 1, 1996, Mr. Tyree was granted an 
option to acquire 2,000 shares at an exercise price of $1.47 per 
share which expires on October 1, 2006.  
The closing bid price of the Company's Common Stock as quoted on 
the NASDAQ System on September 30, 1996 was $1.50 per share.  On 
October 1, 1997, he was granted an option to acquire 2,000 shares 
at an exercise price of $1.1875 per 
share which expires on October 1, 2007.  The closing bid price of 
the Company's Common Stock as quoted on the NASDAQ System on 
September 30, 1997 was $1.1875 per share. On October 1, 1998, he 
was granted an option to acquire 2,000 shares at an exercise 
price of $.4375 per share which expires on October 1, 2008.  The 
closing bid price of the Company's Common Stock as quoted on the 
NASDAQ System on September 30, 1998 was $.4375 per share.  All of 
Mr. Tyree's options currently are exercisable.

(5)  Dr. Walsh, a current member of the Board of Directors, was 
granted an option to acquire 15,000 shares of Common Stock on 
January 31, 1992 for an exercise price of $3.00 per share.  This 
option expires on January 31, 2002.  The closing bid price of the 
Company's Common Stock as quoted on the NASDAQ System on January 
30, 1992 was $2.50 per share.  Dr. Walsh was granted an 
additional option on October 1, 1992 to acquire 667 shares of 
Common Stock at an exercise price of $2.875 per share.  This 
option expires on October 1, 2002.  The closing bid price of the 
Company's Common Stock as quoted on the NASDAQ System on 
September 30, 1992 was $2.625 per share.  Dr. Walsh was granted 
an additional option on October 1, 1993 to acquire 1,000 shares 
of Common Stock at an exercise price of $2.125 per share.  This 
option expires on October 1, 2003.  The closing bid price of the 
Company's Common Stock as quoted on the NASDAQ System on 
September 30, 1993 was $2.00 per share.  The exercise price of 
all of Dr. Walsh's then existing options was reduced to $2.00 per 
share on January 31, 1994.  The closing bid price of the 
Company's Common Stock as quoted on the NASDAQ System on January 
28, 1994 was $4.625 per share.  On October 1, 1994, Dr. Walsh was 
granted an option to acquire 1,000 shares at an exercise price of 
$2.75 per share.  The closing bid price of the Company's Common 
Stock as quoted on the NASDAQ System on September 30, 1994, was 
$2.875 per share.  This option expires on October 1, 2004.  On 
October 1, 1995, Dr. Walsh was granted an option to acquire 1,000 
shares at an exercise price of $.59 per share.  The closing bid 
price of the Company's Common Stock as quoted on the NASDAQ 
System on September 29, 1995, was $.59375 per share.  This option 
expires on October 1, 2005.  On October 1, 1996, Dr. Walsh was 
granted an option to acquire 2,000 shares at an exercise price of 
$1.47 per share which expires on October 1, 2006.  The closing 
bid price of the Company's Common Stock as quoted on the NASDAQ 
System on September 30, 1996 was $1.50 per share. On October 1, 
1997, he was granted an option to acquire 2,000 shares at an 
exercise price of $1.1875 per share which expires on October 1, 
2007.  The closing bid price of the Company's Common Stock as 
quoted on the NASDAQ System on September 30, 1997 was $1.1875 per 
share. On October 1, 1998, he was granted an option to acquire 
2,000 shares at an exercise price of $.4375 per share which 
expires on October 1, 2008.  The closing bid price of the 
Company's Common Stock as quoted on the NASDAQ System on 
September 30, 1998 was $.4375 per share.  All of Dr. Walsh's 
options currently are exercisable.

<PAGE> 8
(6)  Mr. Luther, a current member of the Company's Board of 
Directors, holds warrants to acquire 50,000 shares of Common 
Stock at a price of $0.6407 per share.  These warrants were 
granted as compensation for work per the terms of Mr. Luther's 
agreement with the Company to serve as Senior Vice President of 
Marketing for a term of one year.  In addition, Mr. Luther was 
granted options to acquire 15,000 shares of the Company's Common 
Stock on January 31, 1996, for an exercise price of $.8125 per 
share, which option expires on January 31, 2006. On October 1, 
1996, Mr. Luther was granted an option to acquire 1,333 shares at 
an exercise price of $1.47 per share which expires on October 1, 
2006.  The 
closing bid price of the Company's Common Stock was quoted on the 
NASDAQ System on September 30, 1996 was $1.50 per share.  On 
October 1, 1997, he was granted an option to acquire 2,000 shares 
at an exercise price of $1.1875 per share which expires on 
October 1, 2007.  The closing bid price of the Company's Common 
Stock as quoted on the NASDAQ System on September 30, 1997 was 
$1.1875 per share.  On October 1, 1998, he was granted an option 
to acquire 2,000 shares at an exercise price of $.4375 per share 
which expires on October 1, 2008.  The closing bid price of the 
Company's Common Stock as quoted on the NASDAQ System on 
September 30, 1998 was $.4375 per share.  All of Mr. Luther's 
options are currently exercisable.   Also includes 59,000 shares 
owned by Mr. Luther and held in nominee name.

(7)  Includes options to acquire 30,000 shares of the Company's 
Common Stock granted to Ms. Hunter pursuant to the Company's 1996 
Stock Option Plan.  Such options are exercisable at $0.78125 to 
$1.00 per share and expire as to 15,000 on June 18, 2007 and as 
to 15,000 on October 23, 1997.  Of these options, 10,000 are 
exercisable.  Also includes 2,000 shares owned by Ms. Hunter and 
held in 
nominee name.

PROPOSAL ONE:  TO EFFECT A ONE-FOR-SEVEN REVERSE STOCK SPLIT OF 
THE COMPANY'S COMMON STOCK

The Board of Directors of the Company has approved a resolution 
to effect a one-for-seven reverse split of the Company's issued 
and outstanding shares of Common Stock (the "Reverse Stock 
Split"), subject to the approval of the shareholders.  If the 
Reverse Stock Split is approved by shareholders, the Board of 
Directors will determine the date on which the Reverse Stock 
Split will become effective.  Each share of Common Stock issued 
and outstanding immediately prior to that effective date will be 
reclassified as and changed into one-seventh of one share of 
Common Stock.

<PAGE> 9

PRINCIPAL EFFECTS OF REVERSE STOCK SPLIT

The following table illustrates the principal effects of the 
proposed Reverse Stock Split based on the Company's 
capitalization as of January 5, 1999:

Common Stock  		Prior to Split		After Split

Authorized	    		85,000,000	  		85,000,000

Outstanding		   	64,217,051*	  		9,173,864**

Available For
Future Issuance		20,728,949*		 	75,826,136**

*  Does not assume exercise of any outstanding options or warrants.

**  Assumes that no post-split shares of Common Stock are issued 
in lieu of fractional shares.

The Common Stock issued pursuant to the Reverse Stock Split will 
be fully paid and nonassessable.  The respective relative voting 
rights and other rights that accompany the Common Stock will not 
be altered by the Reverse Stock Split, and the Common Stock will 
continue to have a par value of $0.01 per share.  Consummation of 
the Reverse Stock Split will not alter the number of authorized 
shares of the Company's Common Stock, which will remain at 
85,000,000, of which approximately 75,826,136 shares of Common 
Stock would constitute authorized but unissued and unreserved 
shares.

REASONS FOR THE PROPOSED REVERSE STOCK SPLIT

The Reverse Stock Split is being proposed primarily because the 
Common Stock does not currently meet the requirements for 
continued listing on the Nasdaq Small-Cap Market.  The Nasdaq 
Small-Cap Market continued listing standards include a 
requirement that the closing bid price for a listed company be at 
least $1.00 per share.  Failure to meet this requirement for 30 
consecutive trading days may result in a company being delisted 
from the Nasdaq Small-Cap Market.  When the minimum bid price 
requirement is not met for 30 consecutive trading days, a company 
is delisted unless its closing bid price equals or exceeds $1.00 
for at least ten consecutive trading days during a 90-day period 
following the notice of non-compliance from The Nasdaq Stock 
Market, Inc. ("Nasdaq").

As of July 11, 1998, the closing bid price for the Common Stock 
had been less than $1.00 for more than 30 consecutive trading 
days.  On July 11, 1998, the Company received a notification of 
non-compliance from Nasdaq.  The notification stated that, in 
order to avoid delisting of the Common Stock from the Nasdaq 
Small-Cap Market, the bid price for the Common Stock must close 
at or above $1.00 per share for at least ten consecutive trading 
days before September 11, 1998.  The Common Stock failed to meet 
this minimum bid price requirement during the 90-day period which 
ended September 11, 1998.

<PAGE> 10
On September 11, 1998, the Company filed a request with the 
Nasdaq Listing Qualifications Hearing Department for a hearing to 
contest the delisting of the Common Stock.  The delisting was 
stayed pending the hearing.  Such hearing took place on November 
5, 1998.  On December 1, 1998, the Nasdaq Listing Qualifications 
Panel granted the Company a conditional listing status for the 
Common Stock, but determined that the Common Stock would be 
delisted from the Nasdaq Small-Cap Market unless the Company 
evidenced on or before February 12, 1999, a closing bid price for 
the Common Stock of at least $1.00 for one trading day and, 
immediately thereafter, maintained a closing bid of at least 
$1.00 for a minimum of ten consecutive trading days, as well as 
satisfying all other criteria necessary for continued inclusion 
of the Common Stock on the Nasdaq Small-Cap Market.

As a result of the conditional listing status of the Common 
Stock, effective December 3, 1998, the trading symbol of the 
Common Stock was changed from "GALX" to "GALXC." 

Additionally, the Board of Directors believes that the high 
number of shares of Common Stock outstanding and its relatively 
low per-share market price may adversely effect the trading 
market for the Common Stock and its acceptability to certain 
institutional investors and other members of the investing 
public.  While the number of shares outstanding should not, by 
itself, affect the marketability of a stock, the type of investor 
who acquires such stock or the Company's reputation in the 
financial community, the Company believes that, in practice, this 
is not necessarily the case, as certain investors view low-priced 
as unattractive or, as a matter of policy, are precluded from 
purchasing low-priced shares.  In addition, certain brokerage 
houses, as a matter of policy, will not extend margin credit on 
stocks trading at low prices.  On the other hand, certain other 
investors may be attracted to low-priced stock because of the 
greater trading volatility sometimes associated with such 
securities.

The Board of Directors believes that it is in the best interests 
of the Company and its shareholders to maintain the listing of 
the Common Stock on the Nasdaq Small-Cap Market and that the 
consummation of the proposed Reverse Stock Split will increase 
the price per share of Common Stock to in excess of $1.00.  It is 
anticipated that, if approved by the Company's shareholders, the 
Reverse Stock Split will become effective at the close of 
business on February 11, 1999.

In the event that the Reverse Stock Split is not approved by the 
Company's shareholders, it is likely that the Common Stock will 
be delisted by Nasdaq.  If this were to occur, the Common Stock 
would be traded on the OTC Bulletin Board and would be subject to 
regulations relating to "Penny Stocks" which would immediately 
affect the ability of shareholders to resell their stock and the 
market value for the Common Stock. 

There can be no assurance, even if the Reverse Stock Split is 
consummated, that the bid price per share of Common Stock will 
increase to in excess of $1.00, or that, if the bid price per 
share of Common Stock does increase to in excess of $1.00, that 
such bid price will remain at or above $1.00.  Accordingly, there 
can be no assurance that Nasdaq will not delist the Common Stock 
even if the Reverse Stock Split is consummated.  Additionally, 
there can be no assurance that the Reverse Stock Split will not 
adversely impact the market price of, or the trading market for, 
the Common Stock.

<PAGE> 11
FUTURE DILUTION; ANTI-TAKEOVER EFFECTS

There may be certain disadvantages suffered by shareholders of 
the Company as a result of approval of the Reverse Stock Split.  
These disadvantages include a significant increase in possible 
dilution to present shareholders' percentage ownership of the 
Common Stock because of the additional authorized shares of 
Common Stock which would be available for future issuance by the 
Company.  As illustrated in the table above, present 
shareholders, in the aggregate, own approximately 75.61% of 
current authorized shares of Common Stock under the Company's 
present capital structure, but would own only 10.79% of the 
authorized shares of Common Stock under the Company's post-split 
capital structure, assuming that the proposed Reverse Stock Split 
is consummated.

The proportionate increase in the number of shares of Common 
Stock available for future issuance may also have certain anti-
takeover effects.  For example, the availability of a large 
number of shares of Common Stock for future issuance might allow 
the Company's Board of Directors to dilute the percentage share 
ownership of persons who might attempt to obtain control over the 
Company.  Approval of the Reverse Stock Split therefore, may 
allow the Board of Directors to frustrate a takeover attempt 
which might be favorable to shareholders as a group, and may have 
the effect of limiting shareholder participation in these types 
of transactions.

While the Reverse Stock Split may have certain anti-takeover 
effects, management is not aware of any attempts by third persons 
to accumulate a large number of shares of Common Stock and the 
Board of Directors is not recommending the Reverse Stock Split in 
response to any existing attempts by third parties to obtain 
control of the Company.

REGISTRATION

The Board of Directors believes that the consummation of the 
Reverse Stock Split and the changes which would result therefrom 
will not cause the Company to terminate registration of the 
Common Stock under the Securities Exchange Act of 1934, as 
amended, or to cease filing reports thereunder, and the Company 
does not presently intend to seek, either before or after the 
Reverse Stock Split, any change in the Company's status as a 
reporting company for federal securities law purposes.

FEDERAL INCOME TAX CONSEQUENCES

The receipt of Common Stock in the Reverse Stock Split should not 
result in any taxable gain or loss to shareholders for U.S. 
federal income tax purposes.  If the Reverse Stock Split is 
approved, the U.S. tax basis of Common Stock received as a result 
of the Reverse Stock Split will be equal, in the aggregate, to 
the basis of the shares exchanged for the Common Stock.  For U.S. 
federal income tax purposes, the holding period of the shares 
immediately prior to the effective date of the Reverse Stock 
Split will be included in the holding period of the Common Stock 
received as a result of the Reverse Stock Split.

SHAREHOLDERS ARE ADVISED TO CONSULT THEIR OWN TAX ADVISORS FOR 
MORE DETAILED INFORMATION REGARDING THE EFFECTS OF THE PROPOSED 
REVERSE SPLIT ON THEIR INDIVIDUAL TAX STATUS.

<PAGE> 12
EXCHANGE OF CERTIFICATES

As soon as is practicable following the effective date of the 
Reverse Stock Split, shareholders will be notified and requested 
to surrender their current certificates to the Company's stock 
transfer agent in exchange for the issuance of new certificates 
reflecting the Reverse Stock Split.  Commencing on the effective 
date of the Reverse Stock Split, each certificate representing 
pre-Reverse Stock Split shares of Common Stock will be deemed for 
all purposes to evidence ownership of post-Reverse Stock Split 
shares of Common Stock.  No fractional shares of Common Stock 
will be issued, and, in lieu thereof, assuming approval by the 
shareholders of the Reverse Stock Split, a whole share will be 
issued to any shareholders entitled to a fraction of a share of 
Common Stock.

DETERMINATION BY BOARD TO ABANDON REVERSE STOCK SPLIT

In accordance with Delaware law and notwithstanding approval of 
the proposal by shareholders, at any time prior to the effective 
date of the Reverse Stock Split, the Board of Directors may, in 
its sole discretion, abandon the proposal without any further 
action by shareholders.

REQUISITE VOTE

Assuming the presence of a quorum, the affirmative vote of the 
holders of a majority of the voting power of the outstanding 
shares of Common Stock is necessary for approval of the Reverse 
Stock Split.

THE BOARD OF DIRECTORS RECOMMENDS THAT SHAREHOLDERS VOTE "FOR" 
THE APPROVAL OF THE PROPOSAL TO EFFECT THE REVERSE STOCK SPLIT.

OTHER BUSINESS

The Board of Directors knows of no business that will be 
presented for consideration at the meeting other than stated 
above. If any other business should come before the meeting, 
votes may be cast pursuant to proxies in respect to any such 
business in the best judgment of the person or persons acting 
under the proxies.

EXPENSES AND SOLICITATION

The cost of solicitation of proxies will be borne by the Company. 
In addition to soliciting shareholders by mail of by its regular 
employees, the Company may request banks and brokers to solicit 
their customers who have stock of the Company registered in the 
name of a nominee and, if so, will reimburse such banks and 
brokers for their reasonable out-of-pocket costs.  Solicitation 
by officers and employees of the Company, none of whom will 
receive additional 
compensation therefor, may also be made of some shareholders in 
person or by mail, telephone or telegraph, following the original 
solicitation.

SHAREHOLDER PROPOSALS

It is anticipated that the Company's next annual meeting of 
shareholders will be held in October 1999, and proposals of 
shareholders intended for inclusion in the proxy statement will 
be furnished to all shareholders entitled to vote at 
the next annual meeting of the Company, and must be received at 
the Company's principal executive offices at 2441 Viscount Row, 
Orlando, Florida 32809, no later than July 13, 1999.  It is 
suggested that proponents submit their proposals by Certified 
Mail-Return Receipt Requested.  Notice of shareholder proposals 
outside the processes of Rule 14a-8 of the Securities Exchange 
Act of 1934, as amended, (for proposals submitted for inclusion 
in proxy statement and form of proxy) for the next annual meeting 
of shareholders must be received at the Company's principal 
executive offices no later than September 28, 1999.

<PAGE> 13

GALAXY FOODS COMPANY
PROXY FOR SPECIAL MEETING OF SHAREHOLDERS
THURSDAY, FEBRUARY 11, 1999

This Proxy is Solicited on Behalf of the Board of Directors

The undersigned hereby appoints Angelo S. Morini with full power 
of substitution, the proxies of the undersigned to vote all 
shares of Common Stock of Galaxy Foods Company (the "Company") 
which the undersigned is entitled to vote at the Special Meeting 
of Shareholders of the Company to be held on Thursday, February 
11, 1999, at 10:00 a.m., local time, at the offices of the 
Company located at Orlando Central Park, 2441 Viscount Row, 
Orlando, Florida, and at any adjournments or postponements 
thereof, with the same force and effect as the undersigned might 
or could do if personally present thereof.

			
1.  PROPOSAL TO EFFECT A ONE-FOR-SEVEN REVERSE STOCK SPLIT OF THE 
COMPANY'S COMMON STOCK, PAR VALUE $0.01 PER SHARE. (THE BOARD OF 
DIRECTORS RECOMMENDS A VOTE FOR) 
		       [  ] FOR  			         [  ] AGAINST  	
         [  ] ABSTAIN

2. TO TRANSACT SUCH OTHER BUSINESS AS MAY PROPERLY COME BEFORE 
THE MEETING AND ANY ADJOURNMENT THEREOF
								
The Board of Directors knows of no business that will be 
presented for consideration at the meeting other than stated 
above. If any other business should come before the meeting, 
votes may be cast pursuant to proxies in respect to any such 
business in the best judgment of the person or persons acting 
under the proxies.

Signature:  

_________________________________
					

Signature:  

_________________________________


Date:
  
_________________________________

This Proxy when properly executed will be voted in the manner 
directed herein by the undersigned stockholder.  If no direction 
is made, this proxy will be voted FOR proposal 1.  If signing as 
an attorney, executor, trustee or guardian, please give your full 
title as such.  If stock is held jointly, each owner should sign.

PLEASE MARK, SIGN, DATE AND RETURN THE PROXY CARD PROMPTLY USING 
THE ENCLOSED ENVELOPE



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission